Search

  • Home
  • Recent Issues
  • Articles by Topic
  • Conferences
    • The MedTech Strategist Innovation Summit DUBLIN 2018 – Apr. 17-19
    • The MedTech Strategist Innovation Summit San Francisco 2017 – Nov. 28-29
    • The Medical Alley Innovation Summit Minneapolis 2017 – Sept. 18-19
    • The MedTech Strategist Innovation Summit DUBLIN 2017 – Apr. 25-27
    • Emerging Medical Technologies (EMT) Summit – Nov. 9-11, 2016
    • Innovation In Medtech DUBLIN – April 12-14, 2016
    • Emerging Medical Technologies (EMT) Summit – Oct. 19-21, 2015
    • Other Past Conferences
  • Online Store
  • Contact Us
  • Sign In

Issue: Vol. 2, No. 12, June 30, 2015

Go Back to Medtech Strategist Issue Archive

Table of Contents – The MedTech Strategist, Vol. 2, No. 12, June 30, 2015 (40 Pages):

  • Perspective: “Specialty Drug Pricing Pushback: Is this the Canary in the Mineshaft for Medtech?” by David Cassak
  • Under the Lens: “Elixir Medical’s Contrarian Play in Cardiology: Go Bioresorbable or Go Home,” by Stephen Levin
  • Market Snapshot: “Cartilage Repair: Next-Gen Products Tackle the Challenge,” by Mary Thompson
  • Health Economics: “The Specialty Drug Price Debate: Should Medtech Be Worried?” by David Cassak
  • Medtech Financing: “Half-Year Financing Recap: Crossover Investors Boost Device/Dx Financing; IPO Exits Trump M&A,” by Wendy Diller
  • Start-Ups to Watch: “Autonomic Technologies: Neurostimulation Alleviates Intractable Headache Pain,” by Wendy Diller
  • Start-Ups to Watch: “Renephra: Home-Based Fluid Removal for Fluid Overload and Chronic Edema,” by Mary Stuart
  • Start-Ups to Watch: “Sandstone Diagnostics: A Home-Based Male Fertility Test Becomes a Health Tracker,” by Mary Stuart

 


Articles in This Issue

“Perspective: Specialty Drug Pricing Pushback: Is this the Canary in the Mineshaft for Medtech?” by David Cassak

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

“Under the Lens: Elixir Medical’s Contrarian Play in Cardiology: Go Bioresorbable or Go Home,” by Stephen Levin

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

“Market Snapshot: Cartilage Repair: Next-Gen Products Tackle the Challenge,” by Mary Thompson

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

“Health Economics: The Specialty Drug Price Debate: Should Medtech Be Worried?” by David Cassak

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

“Medtech Financing: Half-Year Financing Recap: Crossover Investors Boost Device/Dx Financing; IPO Exits Trump M&A,” by Wendy Diller

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

“Start-Ups to Watch: Autonomic Technologies: Neurostimulation Alleviates Intractable Headache Pain,” by Wendy Diller

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

“Start-Ups to Watch: Renephra: Home-Based Fluid Removal for Fluid Overload and Chronic Edema,” by Mary Stuart

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

“Start-Ups to Watch: Sandstone Diagnostics: A Home-Based Male Fertility Test Becomes a Health Tracker,” by Mary Stuart

Article Categories:

Biopharma/Biomaterials · Oncology · Perspective & Commentary

Innovation In Medtech, LLC © © 2014–2019 All Rights Reserved.
  • Home
  • Contact
  • #0 (no title)
  • #0 (no title)

Copyright © 2019 · Steve Levin Theme on Genesis Framework · WordPress · Log in